Sunil Healthcare Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 237.02 million compared to INR 306.41 million a year ago. Revenue was INR 239.21 million compared to INR 324.12 million a year ago. Net loss was INR 10.99 million compared to net income of INR 21.27 million a year ago. Basic loss per share from continuing operations was INR 1.07 compared to basic earnings per share from continuing operations of INR 2.07 a year ago. Diluted loss per share from continuing operations was INR 1.07 compared to diluted earnings per share from continuing operations of INR 2.07 a year ago.
For the six months, sales was INR 462.11 million compared to INR 640.47 million a year ago. Revenue was INR 476.19 million compared to INR 567.36 million a year ago. Net loss was INR 17.41 million compared to net income of INR 63.12 million a year ago. Basic loss per share from continuing operations was INR 1.7 compared to basic earnings per share from continuing operations of INR 6.15 a year ago. Diluted loss per share from continuing operations was INR 1.7 compared to diluted earnings per share from continuing operations of INR 6.15 a year ago.